Viva Biotech Holdings (HKG:1873)

Viva Biotech Holdings Ratios and Metrics

Market cap in millions HKD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 12, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,875	1,817	2,249	3,352	9,045	17,492
Market Cap Growth	192.14%	-19.19%	-32.91%	-62.94%	-48.29%	145.61%
Enterprise Value	5,167	2,374	4,227	5,809	10,494	15,958
Last Close Price	2.31	0.86	1.05	1.75	4.71	9.13
PE Ratio	33.78	10.21	-	-	25.63	-
Forward PE	8.17	5.15	5.15	5.17	10.88	23.68
PS Ratio	2.42	0.86	0.95	1.25	3.50	21.13
PB Ratio	1.14	0.45	0.55	0.82	1.88	3.92
P/TBV Ratio	3.18	1.33	1.84	3.05	6.01	10.23
P/FCF Ratio	20.76	9.32	10.43	21.69	-	-
P/OCF Ratio	12.66	4.57	5.32	7.68	94.67	341.11
PEG Ratio	-	0.81	0.81	0.81	0.81	0.39
EV/Sales Ratio	2.57	1.12	1.78	2.16	4.06	19.28
EV/EBITDA Ratio	10.58	5.16	9.81	11.78	23.11	81.76
EV/EBIT Ratio	20.67	9.71	19.92	19.32	36.09	119.41
EV/FCF Ratio	22.00	12.17	19.61	37.58	-	-
Debt / Equity Ratio	0.30	0.34	0.52	0.78	0.68	0.79
Debt / EBITDA Ratio	2.59	2.90	4.71	6.25	6.81	16.25
Debt / FCF Ratio	5.39	7.01	9.72	20.65	-	-
Asset Turnover	0.26	0.27	0.28	0.30	0.26	0.14
Inventory Turnover	4.24	4.88	4.84	5.61	7.33	4.53
Quick Ratio	1.22	1.26	1.03	0.44	1.44	3.75
Current Ratio	1.76	1.67	1.32	0.73	2.14	4.56
Return on Equity (ROE)	5.87%	5.92%	-2.74%	-13.41%	7.84%	-13.69%
Return on Assets (ROA)	2.03%	1.98%	1.57%	2.08%	1.83%	1.40%
Return on Invested Capital (ROIC)	4.41%	3.96%	3.74%	4.62%	4.04%	4.28%
Return on Capital Employed (ROCE)	3.90%	3.90%	3.30%	5.10%	3.30%	1.50%
Earnings Yield	3.87%	9.80%	-5.69%	-17.82%	3.90%	-2.63%
FCF Yield	4.82%	10.73%	9.59%	4.61%	-6.61%	-3.73%
Dividend Yield	-	-	-	-	-	0.30%
Payout Ratio	-	-	-	-	5.66%	-
Buyback Yield / Dilution	-48.61%	-41.39%	-5.91%	2.81%	-25.41%	-5.83%
Total Shareholder Return	-48.61%	-41.39%	-5.91%	2.81%	-25.41%	-5.53%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.